HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
100.20
-0.07 (-0.07%)
Nov 12, 2024, 4:00 PM EST - Market closed
HealthEquity Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for HealthEquity stock have an average target of 103.82, with a low estimate of 92 and a high estimate of 110. The average target predicts an increase of 3.61% from the current stock price of 100.20.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 20, 2024.
Analyst Ratings
The average analyst rating for HealthEquity stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $105 | Buy | Maintains | $105 | +4.79% | Sep 20, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $105 | Buy | Maintains | $105 | +4.79% | Sep 4, 2024 |
| Deutsche Bank | Deutsche Bank | Strong Buy Maintains $102 → $103 | Strong Buy | Maintains | $102 → $103 | +2.79% | Sep 4, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $105 | Buy | Reiterates | $105 | +4.79% | Sep 4, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $92 | Buy | Reiterates | $92 | -8.18% | Sep 4, 2024 |
Financial Forecast
Revenue This Year
1.19B
from 999.59M
Increased by 19.35%
Revenue Next Year
1.33B
from 1.19B
Increased by 11.32%
EPS This Year
3.13
from 0.64
Increased by 388.36%
EPS Next Year
3.73
from 3.13
Increased by 19.39%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.2B | 1.4B | 1.6B |
| Avg | 1.2B | 1.3B | 1.5B |
| Low | 1.2B | 1.2B | 1.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 24.6% | 18.9% | 20.6% |
| Avg | 19.3% | 11.3% | 10.2% |
| Low | 15.1% | 3.4% | -3.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 3.31 | 4.02 | 4.77 |
| Avg | 3.13 | 3.73 | 4.43 |
| Low | 3.00 | 3.52 | 3.96 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 416.8% | 28.7% | 27.8% |
| Avg | 388.4% | 19.4% | 18.7% |
| Low | 368.6% | 12.6% | 6.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.